食管鳞癌中AJUBA突变的分子机制及临床意义
[Abstract]:Background: esophageal cancer is the eighth largest tumor in the world, occupying the sixth place in the death caused by tumor. The majority of esophageal cancer is squamous cell carcinoma. However, the 5-year survival rate of esophageal squamous cell carcinoma is less than 15%, and the total survival time has not been significantly prolonged in recent years, which is related to the lack of effective treatment. With the development of high-throughput sequencing technique, AJUBA gene mutations were found in many esophageal squamous cell carcinoma cohorts, but the related studies were scarce. The molecular mechanism and clinical significance of AJUBA mutation in the carcinogenesis and development of esophageal squamous cell carcinoma were explored. It may improve the prognosis of patients and provide new therapeutic targets. Methods: five cohorts of esophageal squamous cell carcinoma were collected in this paper. All 545 patients had clinical information and total exon sequence data. The correlation between AJUBA mutation and TNM staging was analyzed statistically. The Kaplan-Meier curves of AJUBA mutation and wild-type patients were drawn, and the differences between the two were compared by Log-Rank, in order to obtain the clinical significance of the possible AJUBA mutation and to guide the further exploration of the mechanism and clinical application. At the same time, using 293T cells to package lentivirus, lentivirus infected target cells to construct stable cell lines for studying AJUBA mutation, including stable knockdown cell line, overexpression of wild-type AJUBA cell line and over-expression mutant cell line. By flow cytometry, hygromycin / purine mycin was screened by RT-PCR and Western blotting. On the basis of the constructed cell line, CCK-8 transwell cell function test was carried out to verify the relationship between AJUBA mutation and cell proliferation, migration and invasion in vitro. Results: there was no significant difference in the TNM stages of AJUBA mutation and wild type (Fisher exact probability p1.000) among 545 patients with AJUBA mutation, the Kaplan-Meier curve of AJUBA mutation had a longer survival time (Log-Rank test p0.13). The stable knockdown cell line was constructed and screened by hygromycin / flow fluorescence sorting on 10 days after infection. RT-PCR and Western blotting showed that the knockdown efficiency was not high but the knockdown efficiency was not high. Overexpression wild-type and mutant cell lines were constructed and screened by purine mycin. The results showed that the wild-type AJUBA bands and truncated mutant AJUBA bands were successfully constructed. The proliferative ability of overexpression cell line and wild type cell line was compared by CCK-8. It was found that the proliferation ability of the three overexpression cell lines was stronger than that of wild type cell lines (t test 48h: p0.001p0.001, p0.001; 72h: p0.008, p0.001, p0.001) .Transwell experiment was used to compare the migration and invasion ability between overexpression cell lines and wild type cell lines. The migration ability of three overexpression cell lines was stronger than that of wild type cell lines (t test: p0.001 + p0.001p0.001p0.001), and the invasion ability of overexpression of wild type AJUBA and mutant 1 was stronger than that of wild type cell lines (t test: 0. 001 p0. 001 p0. 035 p0. 576), among them, overexpression of wild type AJUBA cell line was stronger than that of wild type AJUBA cell line. And the most significant enhancement of invasion ability. Conclusion the prognosis of the esophageal squamous cell carcinoma with the mutation of: AJUBA is better than that of the wild type of AJUBA. The construction of stable knockdown cell line could be used as a control for further study and lay a foundation for the construction of mutant AJUBA cell line after knockdown. Overexpression mutant cell line can be used to study AJUBA mutation as a basis for further in vitro experiments. Overexpression of wild-type and mutant AJUBA KYSE450 cell lines have stronger proliferative ability. Overexpression of wild-type and mutant AJUBA in KYSE450 cell lines had stronger migration and invasion ability (except for the invasion ability of mutant 2), especially in the over-expression of wild-type AJUBA cell lines.
【学位授予单位】:北京协和医学院
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R735.1
【相似文献】
相关期刊论文 前10条
1 魏东,黎健,王建业,蒋雷,夏永静,唐蔚青,李红霞,许进,邵鸿勋;野生型p53基因的导入对膀胱癌细胞抑制作用的观察[J];肿瘤;1999年03期
2 朱全胜,丘钜世,王娅兰,张萌;重组野生型p53基因转染人骨肉瘤细胞株体外实验模型的建立[J];郧阳医学院学报;1998年01期
3 傅锐斌;吴平生;邱健;向定成;马骏;洪长江;何建新;;氧浓度和钙离子对野生型及突变型低氧诱导因子-1α基因真核表达的影响[J];南方医科大学学报;2009年07期
4 ;生物学[J];中国医学文摘(基础医学);1987年03期
5 张业,崔玉坤,吴宁华,沈s輙2;野生型p53对热休克蛋白90β基因表达的调控作用[J];基础医学与临床;2000年03期
6 孔祥波,谷新权,马庆杰;野生型p53基因脂质体转染细胞疫苗的制备[J];中国免疫学杂志;2000年08期
7 马峰;史晓宇;孟玮;张敬;赵丽霞;何晓华;赵峻峰;;EGFR野生型晚期非小细胞肺癌的治疗进展[J];中国肺癌杂志;2014年07期
8 欧阳平,刘伊丽,许顶立,侯玉清,黄洪莲,刘新垣;野生型Rb基因转移预防血管成形术后再狭窄的实验研究[J];第一军医大学学报;1998年02期
9 滕宗艳,张一娜,尹新华,凌虹;野生型p53基因转移抑制兔心肌细胞生长的实验研究[J];中国地方病学杂志;2002年05期
10 张玉玲;野生型和突变型APC基因产物之间的联系[J];国外医学(分子生物学分册);1994年01期
相关会议论文 前10条
1 曹宛虹;陈杭;李晓东;辛世文;郑树;;人源野生型p53基因在烟草中的表达[A];2000全国肿瘤学术大会论文集[C];2000年
2 胡柳;李莉;蒋洪;张珈敏;曹旭;胡远扬;;野生型及基因工程蟑螂浓核病毒的电镜分析[A];中南地区第十六届电子显微镜学术交流会论文集[C];2007年
3 李成;李洪涛;廖俊明;马倩;陈杰;梁毅;;SOD1突变体带动野生型SOD1产生纤维样聚集体[A];第一届全国生物物理化学会议暨生物物理化学发展战略研讨会论文摘要集[C];2010年
4 郭颖;;细胞水平野生型和耐药型HIV-1复制模型的建立[A];全国生化与分子药理学药物靶点研讨会论文摘要集[C];2008年
5 梁毅;;野生型SOD1调节突变体SOD1的聚集[A];第十届全国酶学学术讨论会论文集[C];2011年
6 林筱洁;高瑞兰;林圣云;;野生型P53基因在K562细胞内的表达[A];全国中西医结合血液病学术研讨会、浙江省中西医结合学会血液病专业委员会成立大会首次学术年会暨继续教育学习班论文汇编[C];2006年
7 张海江;孙燕;伊丽楠;常梦娇;赵清正;;混合肽疫苗对野生型EGFR人肺癌体内生长的抑制作用[A];2013新型疫苗、重组蛋白及多肽药物研发注册与质量评价研讨会论文集[C];2013年
8 林筱洁;高瑞兰;林圣云;;野生型P53基因在K562细胞内的表达[A];2005年华东六省一市血液病学学术会议暨浙江省血液病学学术年会论文汇编[C];2005年
9 林筱洁;高瑞兰;林圣云;;野生型p53基因在K562细胞内的表达[A];第10届全国实验血液学会议论文摘要汇编[C];2005年
10 ;细胞与分子生物学[A];中国解剖学会2009年年会论文文摘汇编[C];2009年
相关博士学位论文 前10条
1 刘慧芹;番茄疮痂病菌fur基因功能分析及Fe在寄主与病菌互作中的作用[D];山西农业大学;2014年
2 赵鹏;耐辐射异常球菌丙氨酸代谢相关基因在氧化胁迫应答中的作用及其调控[D];西北农林科技大学;2015年
3 白敬;大肠杆菌硝基还原酶NfsB的分子改造及其催化特性[D];大连理工大学;2015年
4 崔一U,
本文编号:2168268
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2168268.html